Diabetes type 1. Type 1 diabetes mellitus
Conditions
Interventions
Intervention 1: Control group: the control group individuals will receive starch tablets which are completely identical in appearance to the supplement and will receive daily for 3 months. Interventi
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Type 1 diabetes Age over 18 years and less than 30 years Able to measure blood sugar daily Be able to measure daily urine ketones HbA1C between 7.5% - 8.5%
Exclusion criteria
Exclusion criteria: Kidney failure Active infection urinary infection pregnancy Cortone use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin A1c. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Electrochemiluminescence Test.;Fasting Blood Sugar. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Electrochemiluminescence Test.;2 hour Post Prandial. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Electrochemiluminescence Test.;Body Mass Index. Timepoint: Baseline and 3 months after the treatment. Method of measurement: weight scale and stadiometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Najafipour
Tabriz University of Medical Sciences
Outcome results
None listed